Fitness Trends Thyroid Cancer Drugs Market | Page 2

(FDA) approved a combination of two targeted drugs, dabrafenib plus trametinib, to treat
patients with anaplastic thyroid cancer. The combination of Tafinlar (dabrafenib) and Mekinist
(trametinib) is the first FDA approved treatment for these type of thyroid cancers. Moreover, in
2015, FDA approved Lenvatinib for the treatment of locally recurrent or metastatic, progressive,
radioactive iodine-refractory differentiated thyroid cancer. In November 2013, U.S. FDA
approved Nexavar (sorafenib) to treat patients with Stage IV thyroid cancer. Moreover, the drug
is already present in the market for the treatment of liver and kidney cancer.
Report includes chapters which deeply display the following deliverable about industry :
• Thyroid Cancer Drugs Market Research Objective and Assumption
• Thyroid Cancer Drugs Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Thyroid Cancer Drugs Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Thyroid Cancer Drugs Market , By Regions
• Thyroid Cancer Drugs Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Thyroid Cancer Drugs Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Thyroid Cancer Drugs Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Thyroid Cancer Drugs Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Thyroid Cancer Drugs Market - Regional Analysis
Geographically, thyroid cancer drugs market is segmented into North America, Latin America,
Europe, Middle East, Asia Pacific, and Africa. North America holds the dominant position in
thyroid cancer drugs market. This is owing to growing prevalence of thyroid cancer in this
region. According to National Cancer Institute (NCI) 2018 data findings, in 2015, there were an